Amyris Completes Full Ownership of Brazilian Fermentation Facility and Expands Production Capabilities
In a significant development for the field of industrial biotechnology, Amyris, Inc., a leading synthetic biology company, has announced its acquisition of Ingredion's 31% stake in the RealSweet Joint Venture. This strategic move grants Amyris complete ownership of its industrial precision fermentation plant located in Barra Bonita, Brazil. The agreement marks a transition from the RealSweet partnership, allowing Ingredion to access Amyris’ proprietary technology for the production and commercialization of fermented Reb M while Amyris will benefit from royalties on future sales of this product.
This decision aligns with Amyris' strategic plan for 2030, which emphasizes expanding their production capabilities and enhancing manufacturing efficiency. The company's investment into the completion of the fourth precision fermentation line at their Barra Bonita facility is set to significantly boost their production capacity and operational flexibility. Expected to become functional in early 2026, this new line will aid in the production of specialty ingredients that are increasingly in demand, thereby positioning Amyris advantageously in the market.
Kathy Fortmann, CEO of Amyris, expressed her enthusiasm, stating that taking full ownership of the cutting-edge fermentation facility is a crucial milestone for optimizing their manufacturing process, ultimately leading to improved profitability. She emphasized the importance of this investment in enhancing the plant's flexibility and accelerating the introduction of innovative, sustainable products.
Jim Zallie, President and CEO of Ingredion, highlighted their excitement about this collaboration, which positions Ingredion to meet the surging global demand for their Stevia offerings. With exclusive access to Amyris’ fermentation technology, they aim to offer a diverse portfolio of sweetener products that meet the growing consumer awareness for clean-label, nature-based solutions.
Nate Yates, Vice President and General Manager at Ingredion, underscored the importance of this partnership in satisfying customer needs for sugar-reduction strategies. They refer to their comprehensive Stevia range as the 'perfectly sweet trifecta'—a combination of extracted, bioconverted, and fermented Reb M.
With over two decades of expertise in synthetic biology, Amyris is dedicated to developing sustainable ingredients through advanced precision fermentation technology. Their innovative approach enables the rapid co-creation of high-performance, sustainable products in collaboration with global partners. Their diverse offerings are incorporated into thousands of end-user products from leading brands, reaching millions of consumers worldwide. Through this strategic acquisition and expansion, Amyris not only reinforces its market position but also emphasizes its commitment to sustainability and innovation in industrial biotechnology.
As the company embarks on this pivotal phase of growth, both Amyris and its partners are excited to meet the evolving demands of consumers who increasingly seek environmentally-conscious and health-oriented products.
In conclusion, Amyris’ full acquisition of the Brazilian fermentation plant represents a critical advancement in its operational capabilities, thereby enhancing its ability to provide high-quality, sustainable ingredients that align with market and consumer trends. Further developments are anticipated as the company implements its strategic initiatives and continues its leadership role in the industry.
This decision aligns with Amyris' strategic plan for 2030, which emphasizes expanding their production capabilities and enhancing manufacturing efficiency. The company's investment into the completion of the fourth precision fermentation line at their Barra Bonita facility is set to significantly boost their production capacity and operational flexibility. Expected to become functional in early 2026, this new line will aid in the production of specialty ingredients that are increasingly in demand, thereby positioning Amyris advantageously in the market.
Kathy Fortmann, CEO of Amyris, expressed her enthusiasm, stating that taking full ownership of the cutting-edge fermentation facility is a crucial milestone for optimizing their manufacturing process, ultimately leading to improved profitability. She emphasized the importance of this investment in enhancing the plant's flexibility and accelerating the introduction of innovative, sustainable products.
Jim Zallie, President and CEO of Ingredion, highlighted their excitement about this collaboration, which positions Ingredion to meet the surging global demand for their Stevia offerings. With exclusive access to Amyris’ fermentation technology, they aim to offer a diverse portfolio of sweetener products that meet the growing consumer awareness for clean-label, nature-based solutions.
Nate Yates, Vice President and General Manager at Ingredion, underscored the importance of this partnership in satisfying customer needs for sugar-reduction strategies. They refer to their comprehensive Stevia range as the 'perfectly sweet trifecta'—a combination of extracted, bioconverted, and fermented Reb M.
With over two decades of expertise in synthetic biology, Amyris is dedicated to developing sustainable ingredients through advanced precision fermentation technology. Their innovative approach enables the rapid co-creation of high-performance, sustainable products in collaboration with global partners. Their diverse offerings are incorporated into thousands of end-user products from leading brands, reaching millions of consumers worldwide. Through this strategic acquisition and expansion, Amyris not only reinforces its market position but also emphasizes its commitment to sustainability and innovation in industrial biotechnology.
As the company embarks on this pivotal phase of growth, both Amyris and its partners are excited to meet the evolving demands of consumers who increasingly seek environmentally-conscious and health-oriented products.
In conclusion, Amyris’ full acquisition of the Brazilian fermentation plant represents a critical advancement in its operational capabilities, thereby enhancing its ability to provide high-quality, sustainable ingredients that align with market and consumer trends. Further developments are anticipated as the company implements its strategic initiatives and continues its leadership role in the industry.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.